Key result
Current exposure to antipsychotics in elderly patients was associated with a decreased risk of hospitalization for acute coronary syndrome compared with past users (adjusted OR 0.5; 95% CI 0.5-0.6).
Why the study?
Does current exposure to antipsychotics reduce the risk of hospitalisation for acute coronary syndrome in elderly de novo users compared to past users?
Case-Control (n=13,827)
Yes
Does current exposure to antipsychotics reduce the risk of hospitalisation for acute coronary syndrome in elderly de novo users compared to past users?
Odds Ratio: 0.5 (95% CI 0.5–0.6)
Current use of antipsychotics in elderly patients is associated with a paradoxically decreased risk of hospitalisation for acute coronary syndrome compared to past use, though this may reflect non-referral bias rather than true cardioprotection.
Should not change prescribing in elderly patients; leaves open bias versus true effect.
OBJECTIVE: To examine the association between antipsychotic use and the risk of acute coronary syndrome (ACS) in elderly de novo users of antipsychotics. DESIGN: A community-based nested case-control study. SETTING: Pharmacy dispensing records from community pharmacies in The Netherlands were linked to hospital discharge records of 950,000 community-dwelling residents from 1998 to 2008. PATIENTS: Cases were 2803 patients aged 60 years or older, with a first hospital admission for ACS identified within a cohort of 26,157 elderly persons with at least one antipsychotic prescription (de novo users). For each case, four controls with no hospitalisation for ACS (n=11,024) were randomly selected from the same cohort, matched by age, gender and duration of registration in the database. MAIN OUTCOME MEASURES: Relative risks, expressed as ORs, for ACS associated with antipsychotic drug use adjusted for comorbidity. RESULTS: Current exposure to antipsychotics was associated with a decreased risk of hospitalisation for ACS compared with past users (adjusted OR 0.5, 95% CI 0.5 to 0.6). Cumulative use up to 100 Defined Daily Doses was also associated with a decreased risk of hospitalisation (OR 0.7, CI 0.6 to 0.8). No differences in risk were found between typical and atypical antipsychotics, current dosage or different degrees of serotonergic, histaminergic or adrenergic affinity of the antipsychotic. CONCLUSIONS: A decreased risk of hospitalisation for ACS in elderly patients currently using antipsychotics was found. Further research is needed to confirm our results and to determine whether there is a cardioprotective effect or a high non-referral rate in elderly antipsychotic users with ACS.
No takes yet. Share an insight, caveat, or question.
Kleijer et al. (2012) conducted a case-control in Acute coronary syndrome (ACS) (n=13,827). Current exposure to antipsychotics vs. Past users was evaluated on Hospitalisation for ACS (OR 0.5, 95% CI 0.5 to 0.6). Current exposure to antipsychotics in elderly patients was associated with a decreased risk of hospitalization for acute coronary syndrome compared with past users (adjusted OR 0.5; 95% CI 0.5-0.6).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: